Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 58 Neoplasms 52 Lung Neoplasms 33 Colorectal Neoplasms 28 Carcinoma, Non-Small-Cell Lung 25 Prostatic Neoplasms 22 Melanoma 19 Pancreatic Neoplasms 17 Ovarian Neoplasms 16 Uterine Cervical Neoplasms 14 Sarcoma 12 Multiple Myeloma 12 Lymphoma 11 Glioma 11 Glioblastoma 11 Neoplasm Metastasis 10 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 10 Neoplastic Cells, Circulating 9 Hematologic Neoplasms 9 Lymphoma, Follicular 8 Head and Neck Neoplasms 8 Leukemia 7 Carcinoma, Hepatocellular 7 Brain Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Papillomavirus Infections 6 Myelodysplastic Syndromes 6 Endometrial Neoplasms 6 Disease 6

Interventions

Doxorubicin 25 Radiotherapy 15 Ifosfamide 14 Trabectedin 10 pazopanib 6 ribociclib 5 pembrolizumab 5 Specimen Handling 5 Gemcitabine 5 Biopsy 5 palbociclib 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Chemotherapy, Adjuvant 4 selinexor 3 liposomal doxorubicin 3 eribulin 3 X-Rays 3 Vincristine 3 Radiation 3 Neoadjuvant Therapy 3 Imatinib Mesylate 3 Filgrastim 3 Etoposide 3 Cyclophosphamide 3 toripalimab 2 temsirolimus 2 romidepsin 2 pegfilgrastim 2 cixutumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liposarcoma × Blood Specimen Collection × Clear all

NCT04224064 2025-02-12

ESPACE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Liposarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡